Notably, leptin may serve as a crucial biological signal for GLP-1, working in synergy, to decrease food intake and body weight
Anything above 35 degrees Celsius begins compromising the peptide structure
In 3-AR knockout mice, however, no effect was observed with AOD9604 confirming the dependency of its chronic lipolytic action on 3-AR expression, while also suggesting an additional acute mechanism that may operate through a separate pathway
A physician-led experiment Steven Klein, an addiction medicine specialist at Caron, is leading a pilot program that represents one of the most extensive real-world tests of GLP-1 drugs for addiction to date
are currently in shortage as of 2024, leaving patients with delays or a complete lack of access to these medicines